CEO Dr Deborah O’Neil and the NovaBiotics team will be attending the BIO CEO & Investor Conference, hosted by the Biotechnology Innovation Organization on the 16th-18th February 2021. Meet with us through the event portal BIO CEO & Investor Event to learn more about our financing plans and strategy for our exciting pipeline of first-in-class antimicrobial and respiratory product candidates including Nylexa for Covid-19.
Recent Posts
- NovaBiotics provides a positive clinical data update for its breakthrough toenail health product, Tinexyl® PRO
- NovaBiotics & Liverpool School of Tropical Medicine Collaborate on Cysteamine Bitartrate as a Potential New Intervention in Mycobacterial Disease.
- The Institute of Podiatrists announce endorsement of Tinexyl PRO
- NovaBiotics Pharma Division Highlighted in Healthcare UK report
- NovaBiotics announces move to ONE BioHub
Recent Comments